Clinical Trials in Arizona

Showing 16461-16480 of 16,770 trials

Pharmacologic Effects of Darifenacin and Tolterodine on Cardiovascular Parameters in Healthy Subjects

NCT00413790

This study will evaluate the pharmacologic effects of exposure to darifenacin and tolterodine on cardiovascular parameters in healthy subjects 50 years of age and older

Healthy

Novartis162 participantsStarted Nov 2006

Scottsdale, Arizona, United States • Tempe, Arizona, United States • San Diego, California, United States +9 more locations

COMPLETEDPhase 231 miles

PLASMA 2 Trial: Examination of Once Daily (QD) Dosing of A-002 In Subjects With Stable Coronary Artery Disease

NCT00525954

The study will be conducted at up to 25 U.S. centers and will be a double-blind randomized parallel group placebo controlled study among subjects with stable coronary artery disease (CAD). Subjects will be randomized to receive either placebo tablets or one of 2 orally active doses of A-002. The duration of study drug therapy will be 8 weeks.

Coronary Artery Disease

Anthera Pharmaceuticals120 participantsStarted Sep 2007

Mobile, Alabama, United States • Scottsdale, Arizona, United States • Hudson, Florida, United States +10 more locations

Pharmacologic Effects of Darifenacin and Tolterodine on Cardiovascular Parameters in Healthy Subjects

PLASMA 2 Trial: Examination of Once Daily (QD) Dosing of A-002 In Subjects With Stable Coronary Artery Disease

Find Trials by Condition in Arizona

Study of Rebamipide Eye Drops to Treat Dry Eye

Patient's Perception of Treatment Outcome With Darifenacin by Patients With Overactive Bladder

Carotid Artery Revascularization Using the Boston Scientific EPI Filter Wire EZ™ and the EndoTex™ NexStent™

Using Behavioral Therapy in Combination With Darifenacin for Symptoms of Overactive Bladder

To Assess Prevention of Bone Loss in Women With Lupus Receiving Treatment With Glucocorticoids

Elsamitrucin (SPI 28090) for Relapsed or Refractory Non-Hodgkin's Lymphoma

Effect of KW-3902IV in Combination With IV Furosemide on Renal Function in Subjects With CHF and Renal Impairment

Safety and Efficacy of Recombinant Adeno-Associated Virus Containing the CFTR Gene in the Treatment of Cystic Fibrosis

Pimecrolimus Cream 1% Plus Topical Corticosteroid in Patients (2-17 Years of Age) With Severe Atopic Dermatitis

Phase 2 Study of VELCADE Alone or VELCADE® Plus Docetaxel in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer

YSPSL for Prevention of Delayed Graft Function Part B

Study of the NDO Endoscopic Plication System For the Treatment of Symptomatic Gastroesophageal Reflux Disease

Endoscopic Full-Thickness Plication for the Treatment of GERD: Long-Term Multicenter Results

Combination of Capecitabine and GTI-2040 in the Treatment of Renal Cell Carcinoma

Safety and Immunological Response Rate Study of THERATOPE® Vaccine in Metastatic Breast Cancer Patients

Dose Escalation Study of KW-3902 on Diuresis in Subjects With Congestive Heart Failure (CHF).

A Trial of Thymalfasin in Adult Patients With Hepatocellular Carcinoma

A Long-Term Study Continuing on From Study 04-001-01 of an Experimental Medication in Adults With Anxiety Disorder